If that was Zantrene’s only use case then i would agree
However we might be pretty close to reviewed validation of FTO as a valid target in clinical setting
A strong result in AML monotherapy with a 50+% R/R could be enough to trigger a deal
Who know’s who JC has been speaking to over the last 12-18 months gearing them up for positive P2 results in AML?
We might be looking at it like its the ugly duckling knowing what FTO & Cardio could be worth, but i assure you BP would waste no time in aquiring it if it meant a quick path to revenue and the other 2 area’s as back up.
A bird in the hand to those guys is certainly better than 999 in the bush.
- Forums
- ASX - By Stock
- Sounds familiar ?
If that was Zantrene’s only use case then i would agree However...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.44 |
Change
0.040(2.86%) |
Mkt cap ! $245.3M |
Open | High | Low | Value | Volume |
$1.45 | $1.49 | $1.41 | $101.7K | 69.88K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9216 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 7767 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 711 | 1.405 |
2 | 5750 | 1.400 |
1 | 2499 | 1.395 |
1 | 1000 | 1.380 |
2 | 8384 | 1.370 |
Price($) | Vol. | No. |
---|---|---|
1.465 | 7767 | 2 |
1.480 | 3000 | 1 |
1.510 | 687 | 1 |
1.545 | 2040 | 1 |
1.550 | 5000 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |